Vera Therapeutics Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Vera Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $77.14. The average 1-year stock price forecast is 125.62% higher than the current stock price, while the lowest is $34 (-0.56%) and the highest is $100 (+192.48%).

Price Target: $77.14 (+125.62%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$34	$77.14	$79	$100
Change	-0.56%	+125.62%	+131.06%	+192.48%

Analyst Ratings

The average analyst rating for Vera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	12	12	12	12	12	12
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	14	14	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Jefferies No rating	Jefferies	Buy Maintains $59	Buy	Maintains	$59	+72.57%	Aug 17, 2026
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Maintains $86 → $76	Buy	Maintains	$86 → $76	+122.29%	Aug 17, 2026
Laura Chico Wedbush	Wedbush	Hold Maintains $34	Hold	Maintains	$34	-0.56%	Aug 17, 2026
Dina Ramadane Bank of America Securities	Bank of America Securities	Buy Reiterates $66	Buy	Reiterates	$66	+93.04%	Aug 14, 2026
Vamil Divan Guggenheim	Guggenheim	Buy Reiterates $76	Buy	Reiterates	$76	+122.29%	Aug 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

25.53M

Revenue Next Year

234.89M

from 25.53M

819.88%

from 25.53M

EPS This Year

-6.32

from -4.66

EPS Next Year

-4.41

from -6.32

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	25.53M
Operating Income	-34.40M	-90.90M	-102.01M	-167.17M	-315.47M	-462.50M
Net Income	-32.61M	-89.06M	-95.99M	-152.15M	-299.62M	-453.51M
EPS	-	-	-	-	-4.66	-6.32
Free Cash Flow	-20.38M	-42.37M	-58.02M	-84.35M	-139.02M	-390.00M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	51.0M
Avg	25.5M
Low	12.1M

Revenue Growth

Chart

Revenue Growth	2027	2028
High	1,374.1%
Avg	819.9%
Low	380.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-5.77
Avg	-6.32
Low	-7.11

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-